InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by SMITH PATRICK F, Président, Développement Intégré des Médicaments. Director active across 2 companies, notably Certara, Inc.. Aggregated, 4 disclosures have been recorded. Total volume traded: €179k. The latest transaction was filed on 8 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€178,77010,000 shares@ €17.8770.013% mcap85.7% of flow
Common Stock
SEC:0001415889-22-006381:0·
€29,7201,532 shares@ €19.39970.0021% mcap14.3% of flow
Common Stock
SEC:0001415889-22-003827:0·
03,631 shares0
Common Stock
SEC:0001415889-21-005033·
03,631 shares0
Common Stock
SEC:0001415889-21-005033:0·
4 of 4 declarations
About SMITH PATRICK F
Patrick F. Smith is the President of Integrated Drug Development at Certara, Inc. He leads integrated drug development initiatives, focusing on innovation and process efficiency.
